Upcoming Health Conferences in Boston, United States

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The C...

Turbocharged by increased LNP pipeline development and technological advancements with SPARTA biodiscovery raising $4.3m for their characterization...

Presenting Cancer 2024, a groundbreaking Event, in Boston, USA. Join us for the "2nd International Conference on Innovations and Advances in Cancer...

Raw materials play a critical role in the development of cell and gene therapies and their quality directly affects the stability, safety, potency,...

As drug developers continue to utilize the expedited FDA regulatory pathway available for CBD, alongside a growing interest in the therapeutic bene...

Supercharge Your R and D, Diagnostic and GMP Operations Across Asset and Facilities' Productivity, Capital Efficiency and Sustainability through In...

In light of Anavex's announcement of its first entire clinical gene pathway data in patients with Rett syndrome, coupled with Mission Therapeutics'...

Designed for the CHRO/CPO/Head of HR at the Heart of Emerging Biopharma Organizations Mark your calendars for November because LEAP HR: Emerging B...

The inaugural Portfolio Strategy and Decision Making for Biopharma Summit is a must-attend event for leaders in the pharma and biotech industries w...

The 5th Genome Editing Therapeutics Summit (formerly CRISPR 2.0) is the industry's foremost meeting for spearheading the development, application, ...

CNS drug development is facing a new era, thanks to huge strides in neuroscience innovation, including advances in blood-brain barrier transport, C...

Demonstrating your cell therapy's superior safety and efficacy is vital for standing out in a competitive market and attracting investment. Integra...